This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Global Blood Therapeutics, Inc.. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Eleanor L. Ramos: Innovator in Sickle Cell Disease Treatment
Introduction
Eleanor L. Ramos is a prominent inventor based in South San Francisco, CA (US). She has made significant contributions to the field of medicine, particularly in the treatment of sickle cell disease. With a total of 2 patents, her work is paving the way for innovative therapeutic approaches.
Latest Patents
Eleanor's latest patents focus on dosing regimens for a compound known as 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde. These patents provide methods for treating sickle cell disease by administering this compound or its polymorphs in specific dosing regimens. This innovative approach aims to improve the quality of life for individuals affected by this condition.
Career Highlights
Eleanor L. Ramos is currently associated with Global Blood Therapeutics, Inc., where she continues to develop groundbreaking treatments for sickle cell disease. Her dedication to research and innovation has positioned her as a key figure in the medical community.
Collaborations
Eleanor collaborates with talented professionals such as Athiwat Hutchaleelaha and Joshua Eli Lehrer-Graiwer. These partnerships enhance her research efforts and contribute to the advancement of treatment options for sickle cell disease.
Conclusion
Eleanor L. Ramos is a remarkable inventor whose work is making a significant impact in the field of medicine. Her innovative patents and collaborations are essential in the ongoing fight against sickle cell disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
